Scynexis (SCYX) Capital Expenditures Growth (5y) (2018 - 2021)
Scynexis (SCYX) Capital Expenditures Growth (5y) (2018 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.21 Bn | 39.55 Bn | 2.15 Bn |
| 3 | Zoetis | 31.48 Bn | 29.80 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.49 Bn | 15.10 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -176.40% |
| Sep 30, 2021 | 88.02% |
| Mar 31, 2021 | 66.29% |
| Dec 31, 2020 | -15.94% |
| Sep 30, 2020 | -27.52% |
| Dec 31, 2018 | 7.60% |
| Sep 30, 2018 | 3.29% |
| Jun 30, 2018 | 53.46% |
| Mar 31, 2018 | -48.12% |